Delivery Order SPE2DB20D2104-SPE2DB24FS09D

Award Date 1/17/24
Potential Completion Date 1/18/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,788.22 firm fixed-price contract is for the supply of Janumet 50-1,000 mg tablets in 180-count packages. The contract has an ultimate completion date of May 9, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Janumet 50-1,000 mg tablets. The contract has a ceiling value of $5,565.46 and an ultimate completion date of August 12, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,905.76 firm fixed-price contract is for the supply of 180 tablets of the drug Janumet 50-1,000 mg. The contract has a completion date of May 31, 2023. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $14,601.84 firm fixed-price contract is for the supply of 180 units of the pharmaceutical product Janumet 50-1,000 mg tablet. The contract has an ultimate completion date of November 15, 2022 and is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET 50-1,000 mg tablets. The contract has a ceiling value of $1,006.03 and runs through November 25, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET 50-1,000 mg tablets. The contract is a firm-fixed price delivery order with a ceiling value of $21,729.58 and a completion date of July 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,151.92 firm fixed-price contract is for the delivery of JANUMET 50-1,000 milligram tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Janumet 50-1,000 mg tablets in 180-count bottles. The contract has a ceiling value of $10,060.62 and a completion date of September 6, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,408.84 firm fixed-price contract provides the DLA with JANUMET 50-1,000 mg tablets over a period ending on June 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET 50-1,000 mg tablets. The one-year contract, valued at $5,090.76, is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FS09D
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,266.04 firm fixed price contract is for the supply of Janumet 50-1,000 mg tablets in quantities of 180 per bottle. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. This delivery order was not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 12:27 PM